0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biocompatibility Testing Market Research Report 2026
Published Date: 2026-03-04
|
Report Code: QYRE-Auto-29C17459
Home | Market Reports
Global Biocompatibility Testing Market Research Report 2024
BUY CHAPTERS

Global Biocompatibility Testing Market Research Report 2026

Code: QYRE-Auto-29C17459
Report
2026-03-04
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biocompatibility Testing Market

The global Biocompatibility Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Biocompatibility Testing is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Biocompatibility Testing is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Biocompatibility Testing in Clinical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Biocompatibility Testing include Eurofins, Charles River, TUV SUD, Intertek Group, WuXi AppTec, LabCorp, Syensqo, SGS, Nelson Labs, Pacific BioLabs, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Biocompatibility Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biocompatibility Testing. The Biocompatibility Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Biocompatibility Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Biocompatibility Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Biocompatibility Testing Market Report

Report Metric Details
Report Name Biocompatibility Testing Market
Segment by Type
  • Cytotoxicity
  • Sensitization
  • Irritant
  • Pyrogen
  • Other
Segment by Application
  • Clinical
  • Non-clinical
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins, Charles River, TUV SUD, Intertek Group, WuXi AppTec, LabCorp, Syensqo, SGS, Nelson Labs, Pacific BioLabs, Vantage MedTech, Cormica Lab (Wickham Micro), CTI, CIRS, Shenzhen Advanced, Kerbio, CAS Testing, PONY Medicine, Tigermed, King Rock
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Biocompatibility Testing companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Biocompatibility Testing Market report?

Ans: The main players in the Biocompatibility Testing Market are Eurofins, Charles River, TUV SUD, Intertek Group, WuXi AppTec, LabCorp, Syensqo, SGS, Nelson Labs, Pacific BioLabs, Vantage MedTech, Cormica Lab (Wickham Micro), CTI, CIRS, Shenzhen Advanced, Kerbio, CAS Testing, PONY Medicine, Tigermed, King Rock

What are the Application segmentation covered in the Biocompatibility Testing Market report?

Ans: The Applications covered in the Biocompatibility Testing Market report are Clinical, Non-clinical

What are the Type segmentation covered in the Biocompatibility Testing Market report?

Ans: The Types covered in the Biocompatibility Testing Market report are Cytotoxicity, Sensitization, Irritant, Pyrogen, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biocompatibility Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Cytotoxicity
1.2.3 Sensitization
1.2.4 Irritant
1.2.5 Pyrogen
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biocompatibility Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Clinical
1.3.3 Non-clinical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biocompatibility Testing Market Perspective (2021–2032)
2.2 Global Biocompatibility Testing Growth Trends by Region
2.2.1 Global Biocompatibility Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Biocompatibility Testing Historic Market Size by Region (2021–2026)
2.2.3 Biocompatibility Testing Forecasted Market Size by Region (2027–2032)
2.3 Biocompatibility Testing Market Dynamics
2.3.1 Biocompatibility Testing Industry Trends
2.3.2 Biocompatibility Testing Market Drivers
2.3.3 Biocompatibility Testing Market Challenges
2.3.4 Biocompatibility Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biocompatibility Testing Players by Revenue
3.1.1 Global Top Biocompatibility Testing Players by Revenue (2021–2026)
3.1.2 Global Biocompatibility Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Biocompatibility Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Biocompatibility Testing Revenue
3.4 Global Biocompatibility Testing Market Concentration Ratio
3.4.1 Global Biocompatibility Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biocompatibility Testing Revenue in 2025
3.5 Global Key Players of Biocompatibility Testing Head Offices and Areas Served
3.6 Global Key Players of Biocompatibility Testing, Products and Applications
3.7 Global Key Players of Biocompatibility Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Biocompatibility Testing Breakdown Data by Type
4.1 Global Biocompatibility Testing Historic Market Size by Type (2021–2026)
4.2 Global Biocompatibility Testing Forecasted Market Size by Type (2027–2032)
5 Biocompatibility Testing Breakdown Data by Application
5.1 Global Biocompatibility Testing Historic Market Size by Application (2021–2026)
5.2 Global Biocompatibility Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Biocompatibility Testing Market Size (2021–2032)
6.2 North America Biocompatibility Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Biocompatibility Testing Market Size by Country (2021–2026)
6.4 North America Biocompatibility Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biocompatibility Testing Market Size (2021–2032)
7.2 Europe Biocompatibility Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Biocompatibility Testing Market Size by Country (2021–2026)
7.4 Europe Biocompatibility Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Biocompatibility Testing Market Size (2021–2032)
8.2 Asia-Pacific Biocompatibility Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Biocompatibility Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Biocompatibility Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Biocompatibility Testing Market Size (2021–2032)
9.2 Latin America Biocompatibility Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Biocompatibility Testing Market Size by Country (2021–2026)
9.4 Latin America Biocompatibility Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biocompatibility Testing Market Size (2021–2032)
10.2 Middle East & Africa Biocompatibility Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Biocompatibility Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Biocompatibility Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins
11.1.1 Eurofins Company Details
11.1.2 Eurofins Business Overview
11.1.3 Eurofins Biocompatibility Testing Introduction
11.1.4 Eurofins Revenue in Biocompatibility Testing Business (2021–2026)
11.1.5 Eurofins Recent Development
11.2 Charles River
11.2.1 Charles River Company Details
11.2.2 Charles River Business Overview
11.2.3 Charles River Biocompatibility Testing Introduction
11.2.4 Charles River Revenue in Biocompatibility Testing Business (2021–2026)
11.2.5 Charles River Recent Development
11.3 TUV SUD
11.3.1 TUV SUD Company Details
11.3.2 TUV SUD Business Overview
11.3.3 TUV SUD Biocompatibility Testing Introduction
11.3.4 TUV SUD Revenue in Biocompatibility Testing Business (2021–2026)
11.3.5 TUV SUD Recent Development
11.4 Intertek Group
11.4.1 Intertek Group Company Details
11.4.2 Intertek Group Business Overview
11.4.3 Intertek Group Biocompatibility Testing Introduction
11.4.4 Intertek Group Revenue in Biocompatibility Testing Business (2021–2026)
11.4.5 Intertek Group Recent Development
11.5 WuXi AppTec
11.5.1 WuXi AppTec Company Details
11.5.2 WuXi AppTec Business Overview
11.5.3 WuXi AppTec Biocompatibility Testing Introduction
11.5.4 WuXi AppTec Revenue in Biocompatibility Testing Business (2021–2026)
11.5.5 WuXi AppTec Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Biocompatibility Testing Introduction
11.6.4 LabCorp Revenue in Biocompatibility Testing Business (2021–2026)
11.6.5 LabCorp Recent Development
11.7 Syensqo
11.7.1 Syensqo Company Details
11.7.2 Syensqo Business Overview
11.7.3 Syensqo Biocompatibility Testing Introduction
11.7.4 Syensqo Revenue in Biocompatibility Testing Business (2021–2026)
11.7.5 Syensqo Recent Development
11.8 SGS
11.8.1 SGS Company Details
11.8.2 SGS Business Overview
11.8.3 SGS Biocompatibility Testing Introduction
11.8.4 SGS Revenue in Biocompatibility Testing Business (2021–2026)
11.8.5 SGS Recent Development
11.9 Nelson Labs
11.9.1 Nelson Labs Company Details
11.9.2 Nelson Labs Business Overview
11.9.3 Nelson Labs Biocompatibility Testing Introduction
11.9.4 Nelson Labs Revenue in Biocompatibility Testing Business (2021–2026)
11.9.5 Nelson Labs Recent Development
11.10 Pacific BioLabs
11.10.1 Pacific BioLabs Company Details
11.10.2 Pacific BioLabs Business Overview
11.10.3 Pacific BioLabs Biocompatibility Testing Introduction
11.10.4 Pacific BioLabs Revenue in Biocompatibility Testing Business (2021–2026)
11.10.5 Pacific BioLabs Recent Development
11.11 Vantage MedTech
11.11.1 Vantage MedTech Company Details
11.11.2 Vantage MedTech Business Overview
11.11.3 Vantage MedTech Biocompatibility Testing Introduction
11.11.4 Vantage MedTech Revenue in Biocompatibility Testing Business (2021–2026)
11.11.5 Vantage MedTech Recent Development
11.12 Cormica Lab (Wickham Micro)
11.12.1 Cormica Lab (Wickham Micro) Company Details
11.12.2 Cormica Lab (Wickham Micro) Business Overview
11.12.3 Cormica Lab (Wickham Micro) Biocompatibility Testing Introduction
11.12.4 Cormica Lab (Wickham Micro) Revenue in Biocompatibility Testing Business (2021–2026)
11.12.5 Cormica Lab (Wickham Micro) Recent Development
11.13 CTI
11.13.1 CTI Company Details
11.13.2 CTI Business Overview
11.13.3 CTI Biocompatibility Testing Introduction
11.13.4 CTI Revenue in Biocompatibility Testing Business (2021–2026)
11.13.5 CTI Recent Development
11.14 CIRS
11.14.1 CIRS Company Details
11.14.2 CIRS Business Overview
11.14.3 CIRS Biocompatibility Testing Introduction
11.14.4 CIRS Revenue in Biocompatibility Testing Business (2021–2026)
11.14.5 CIRS Recent Development
11.15 Shenzhen Advanced
11.15.1 Shenzhen Advanced Company Details
11.15.2 Shenzhen Advanced Business Overview
11.15.3 Shenzhen Advanced Biocompatibility Testing Introduction
11.15.4 Shenzhen Advanced Revenue in Biocompatibility Testing Business (2021–2026)
11.15.5 Shenzhen Advanced Recent Development
11.16 Kerbio
11.16.1 Kerbio Company Details
11.16.2 Kerbio Business Overview
11.16.3 Kerbio Biocompatibility Testing Introduction
11.16.4 Kerbio Revenue in Biocompatibility Testing Business (2021–2026)
11.16.5 Kerbio Recent Development
11.17 CAS Testing
11.17.1 CAS Testing Company Details
11.17.2 CAS Testing Business Overview
11.17.3 CAS Testing Biocompatibility Testing Introduction
11.17.4 CAS Testing Revenue in Biocompatibility Testing Business (2021–2026)
11.17.5 CAS Testing Recent Development
11.18 PONY Medicine
11.18.1 PONY Medicine Company Details
11.18.2 PONY Medicine Business Overview
11.18.3 PONY Medicine Biocompatibility Testing Introduction
11.18.4 PONY Medicine Revenue in Biocompatibility Testing Business (2021–2026)
11.18.5 PONY Medicine Recent Development
11.19 Tigermed
11.19.1 Tigermed Company Details
11.19.2 Tigermed Business Overview
11.19.3 Tigermed Biocompatibility Testing Introduction
11.19.4 Tigermed Revenue in Biocompatibility Testing Business (2021–2026)
11.19.5 Tigermed Recent Development
11.20 King Rock
11.20.1 King Rock Company Details
11.20.2 King Rock Business Overview
11.20.3 King Rock Biocompatibility Testing Introduction
11.20.4 King Rock Revenue in Biocompatibility Testing Business (2021–2026)
11.20.5 King Rock Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Biocompatibility Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Cytotoxicity
 Table 3. Key Players of Sensitization
 Table 4. Key Players of Irritant
 Table 5. Key Players of Pyrogen
 Table 6. Key Players of Other
 Table 7. Global Biocompatibility Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Biocompatibility Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 9. Global Biocompatibility Testing Market Size by Region (US$ Million), 2021–2026
 Table 10. Global Biocompatibility Testing Market Share by Region (2021–2026)
 Table 11. Global Biocompatibility Testing Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 12. Global Biocompatibility Testing Market Share by Region (2027–2032)
 Table 13. Biocompatibility Testing Market Trends
 Table 14. Biocompatibility Testing Market Drivers
 Table 15. Biocompatibility Testing Market Challenges
 Table 16. Biocompatibility Testing Market Restraints
 Table 17. Global Biocompatibility Testing Revenue by Players (US$ Million), 2021–2026
 Table 18. Global Biocompatibility Testing Market Share by Players (2021–2026)
 Table 19. Global Top Biocompatibility Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Biocompatibility Testing Revenue, 2025
 Table 20. Ranking of Global Top Biocompatibility Testing Companies by Revenue (US$ Million) in 2025
 Table 21. Global 5 Largest Players Market Share by Biocompatibility Testing Revenue (CR5 and HHI), 2021–2026
 Table 22. Global Key Players of Biocompatibility Testing, Headquarters and Area Served
 Table 23. Global Key Players of Biocompatibility Testing, Products and Applications
 Table 24. Global Key Players of Biocompatibility Testing, Date of General Availability (GA)
 Table 25. Mergers and Acquisitions, Expansion Plans
 Table 26. Global Biocompatibility Testing Market Size by Type (US$ Million), 2021–2026
 Table 27. Global Biocompatibility Testing Revenue Market Share by Type (2021–2026)
 Table 28. Global Biocompatibility Testing Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 29. Global Biocompatibility Testing Revenue Market Share by Type (2027–2032)
 Table 30. Global Biocompatibility Testing Market Size by Application (US$ Million), 2021–2026
 Table 31. Global Biocompatibility Testing Revenue Market Share by Application (2021–2026)
 Table 32. Global Biocompatibility Testing Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 33. Global Biocompatibility Testing Revenue Market Share by Application (2027–2032)
 Table 34. North America Biocompatibility Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. North America Biocompatibility Testing Market Size by Country (US$ Million), 2021–2026
 Table 36. North America Biocompatibility Testing Market Size by Country (US$ Million), 2027–2032
 Table 37. Europe Biocompatibility Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Europe Biocompatibility Testing Market Size by Country (US$ Million), 2021–2026
 Table 39. Europe Biocompatibility Testing Market Size by Country (US$ Million), 2027–2032
 Table 40. Asia-Pacific Biocompatibility Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Asia-Pacific Biocompatibility Testing Market Size by Region (US$ Million), 2021–2026
 Table 42. Asia-Pacific Biocompatibility Testing Market Size by Region (US$ Million), 2027–2032
 Table 43. Latin America Biocompatibility Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Latin America Biocompatibility Testing Market Size by Country (US$ Million), 2021–2026
 Table 45. Latin America Biocompatibility Testing Market Size by Country (US$ Million), 2027–2032
 Table 46. Middle East & Africa Biocompatibility Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Middle East & Africa Biocompatibility Testing Market Size by Country (US$ Million), 2021–2026
 Table 48. Middle East & Africa Biocompatibility Testing Market Size by Country (US$ Million), 2027–2032
 Table 49. Eurofins Company Details
 Table 50. Eurofins Business Overview
 Table 51. Eurofins Biocompatibility Testing Product
 Table 52. Eurofins Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 53. Eurofins Recent Development
 Table 54. Charles River Company Details
 Table 55. Charles River Business Overview
 Table 56. Charles River Biocompatibility Testing Product
 Table 57. Charles River Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 58. Charles River Recent Development
 Table 59. TUV SUD Company Details
 Table 60. TUV SUD Business Overview
 Table 61. TUV SUD Biocompatibility Testing Product
 Table 62. TUV SUD Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 63. TUV SUD Recent Development
 Table 64. Intertek Group Company Details
 Table 65. Intertek Group Business Overview
 Table 66. Intertek Group Biocompatibility Testing Product
 Table 67. Intertek Group Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 68. Intertek Group Recent Development
 Table 69. WuXi AppTec Company Details
 Table 70. WuXi AppTec Business Overview
 Table 71. WuXi AppTec Biocompatibility Testing Product
 Table 72. WuXi AppTec Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 73. WuXi AppTec Recent Development
 Table 74. LabCorp Company Details
 Table 75. LabCorp Business Overview
 Table 76. LabCorp Biocompatibility Testing Product
 Table 77. LabCorp Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 78. LabCorp Recent Development
 Table 79. Syensqo Company Details
 Table 80. Syensqo Business Overview
 Table 81. Syensqo Biocompatibility Testing Product
 Table 82. Syensqo Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 83. Syensqo Recent Development
 Table 84. SGS Company Details
 Table 85. SGS Business Overview
 Table 86. SGS Biocompatibility Testing Product
 Table 87. SGS Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 88. SGS Recent Development
 Table 89. Nelson Labs Company Details
 Table 90. Nelson Labs Business Overview
 Table 91. Nelson Labs Biocompatibility Testing Product
 Table 92. Nelson Labs Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 93. Nelson Labs Recent Development
 Table 94. Pacific BioLabs Company Details
 Table 95. Pacific BioLabs Business Overview
 Table 96. Pacific BioLabs Biocompatibility Testing Product
 Table 97. Pacific BioLabs Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 98. Pacific BioLabs Recent Development
 Table 99. Vantage MedTech Company Details
 Table 100. Vantage MedTech Business Overview
 Table 101. Vantage MedTech Biocompatibility Testing Product
 Table 102. Vantage MedTech Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 103. Vantage MedTech Recent Development
 Table 104. Cormica Lab (Wickham Micro) Company Details
 Table 105. Cormica Lab (Wickham Micro) Business Overview
 Table 106. Cormica Lab (Wickham Micro) Biocompatibility Testing Product
 Table 107. Cormica Lab (Wickham Micro) Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 108. Cormica Lab (Wickham Micro) Recent Development
 Table 109. CTI Company Details
 Table 110. CTI Business Overview
 Table 111. CTI Biocompatibility Testing Product
 Table 112. CTI Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 113. CTI Recent Development
 Table 114. CIRS Company Details
 Table 115. CIRS Business Overview
 Table 116. CIRS Biocompatibility Testing Product
 Table 117. CIRS Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 118. CIRS Recent Development
 Table 119. Shenzhen Advanced Company Details
 Table 120. Shenzhen Advanced Business Overview
 Table 121. Shenzhen Advanced Biocompatibility Testing Product
 Table 122. Shenzhen Advanced Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 123. Shenzhen Advanced Recent Development
 Table 124. Kerbio Company Details
 Table 125. Kerbio Business Overview
 Table 126. Kerbio Biocompatibility Testing Product
 Table 127. Kerbio Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 128. Kerbio Recent Development
 Table 129. CAS Testing Company Details
 Table 130. CAS Testing Business Overview
 Table 131. CAS Testing Biocompatibility Testing Product
 Table 132. CAS Testing Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 133. CAS Testing Recent Development
 Table 134. PONY Medicine Company Details
 Table 135. PONY Medicine Business Overview
 Table 136. PONY Medicine Biocompatibility Testing Product
 Table 137. PONY Medicine Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 138. PONY Medicine Recent Development
 Table 139. Tigermed Company Details
 Table 140. Tigermed Business Overview
 Table 141. Tigermed Biocompatibility Testing Product
 Table 142. Tigermed Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 143. Tigermed Recent Development
 Table 144. King Rock Company Details
 Table 145. King Rock Business Overview
 Table 146. King Rock Biocompatibility Testing Product
 Table 147. King Rock Revenue in Biocompatibility Testing Business (US$ Million), 2021–2026
 Table 148. King Rock Recent Development
 Table 149. Research Programs/Design for This Report
 Table 150. Key Data Information from Secondary Sources
 Table 151. Key Data Information from Primary Sources
 Table 152. Authors List of This Report


List of Figures
 Figure 1. Biocompatibility Testing Picture
 Figure 2. Global Biocompatibility Testing Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Biocompatibility Testing Market Share by Type: 2025 vs 2032
 Figure 4. Cytotoxicity Features
 Figure 5. Sensitization Features
 Figure 6. Irritant Features
 Figure 7. Pyrogen Features
 Figure 8. Other Features
 Figure 9. Global Biocompatibility Testing Market Size by Application (US$ Million), 2021–2032
 Figure 10. Global Biocompatibility Testing Market Share by Application: 2025 vs 2032
 Figure 11. Clinical Case Studies
 Figure 12. Non-clinical Case Studies
 Figure 13. Biocompatibility Testing Report Years Considered
 Figure 14. Global Biocompatibility Testing Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Biocompatibility Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Biocompatibility Testing Market Share by Region: 2025 vs 2032
 Figure 17. Global Biocompatibility Testing Market Share by Players in 2025
 Figure 18. Global Biocompatibility Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Biocompatibility Testing Revenue in 2025
 Figure 20. North America Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Biocompatibility Testing Market Share by Country (2021–2032)
 Figure 22. United States Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Biocompatibility Testing Market Share by Country (2021–2032)
 Figure 26. Germany Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Biocompatibility Testing Market Share by Region (2021–2032)
 Figure 34. China Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Biocompatibility Testing Market Share by Country (2021–2032)
 Figure 42. Mexico Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Biocompatibility Testing Market Share by Country (2021–2032)
 Figure 46. Israel Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Biocompatibility Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Eurofins Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 50. Charles River Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 51. TUV SUD Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 52. Intertek Group Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 53. WuXi AppTec Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 54. LabCorp Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 55. Syensqo Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 56. SGS Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 57. Nelson Labs Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 58. Pacific BioLabs Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 59. Vantage MedTech Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 60. Cormica Lab (Wickham Micro) Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 61. CTI Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 62. CIRS Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 63. Shenzhen Advanced Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 64. Kerbio Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 65. CAS Testing Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 66. PONY Medicine Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 67. Tigermed Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 68. King Rock Revenue Growth Rate in Biocompatibility Testing Business (2021–2026)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools